Vicapsys Life Sciences, Inc. financial data

Symbol
VICP
Location
1735 Buford Highway, Ste. 215 113, Cumming, GA
State of incorporation
FL
Fiscal year end
December 31
Former names
SSGI, INC. (to 11/7/2016)
Latest financial report
10-K - Q4 2023 - Oct 21, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11.2 % +58.8%
Return On Equity 86 % -51.4%
Return On Assets -686 % -129%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.1M shares 0%
Common Stock, Shares, Outstanding 32.1M shares +2.83%
Entity Public Float 4.66M USD
Common Stock, Value, Issued 32.1K USD +2.83%
Weighted Average Number of Shares Outstanding, Basic 34.5M shares +13%
Weighted Average Number of Shares Outstanding, Diluted 34.5M shares +13%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.3K USD
General and Administrative Expense 96.4K USD +60.2%
Operating Income (Loss) -1.05M USD -6.32%
Nonoperating Income (Expense) -64.9K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.18M USD -20%
Net Income (Loss) Attributable to Parent -1.18M USD -20%
Earnings Per Share, Basic -0.03 USD/shares 0%
Earnings Per Share, Diluted -0.03 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.42K USD -33.2%
Assets, Current 39.7K USD -44.9%
Intangible Assets, Net (Excluding Goodwill) 348K USD -8.26%
Assets 39.7K USD -44.9%
Accounts Payable, Current 537K USD +97.4%
Liabilities, Current 1.97M USD +92.4%
Retained Earnings (Accumulated Deficit) -16.3M USD -7.82%
Stockholders' Equity Attributable to Parent -1.93M USD -103%
Liabilities and Equity 39.7K USD -44.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.96K USD +91.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 32.1M shares +2.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.96K USD +91.4%
Deferred Tax Assets, Valuation Allowance 2.99M USD +8.9%
Deferred Tax Assets, Operating Loss Carryforwards 2.99M USD +8.9%
Preferred Stock, Shares Authorized 7.44M shares 0%
Additional Paid in Capital 14.3M USD +1.44%
Interest Expense 9.95K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%